A class of diabetes drugs that include Merck & Co Inc’s Januvia has been linked with severe joint pain, the U.S. Food and Drug Administration said on Friday.The FDA said it had identified 33 cases of severe joint pain in patients taking a class of drugs known as DPP-4 inhibitors between Oct. 16, 2006, when the first one was approved, through Dec. 31, 2013.